-

The Trump-Elon Musk Feud Creates More Problems for Tesla
Already suffering from steep declines in sales and profit, the carmaker could now face the president’s wrath.
-

Five Big Midterm Questions That Could Shape Democrats’ 2028 Field
Before they can run in 2028, numerous top Democrats will first face re-election in 2026. And for everyone, the midterms will serve as a new political proving ground.
-

Trump’s International Student Ban Sparks Fear Among Harvard Attendees
Alfred Williamson could not have imagined how much his freshman year would be shaped by the Trump administration, inside and outside the classroom.
-

Chinese Students Reconsider the U.S. as Republicans Threaten Their Visas
Critics say proposals to restrict or even ban Chinese student visas take a “sledgehammer to a problem that needs highly targeted tools.”
-

Google Pays $50 Million to Settle Class Action Allegations of ‘Racially Biased Corporate Structure’
On September 11, 2024, the U.S. Equal Employment Opportunity Commission (EEOC) released a report titled “High Tech, Low Inclusion: Diversity in the High Tech Workforce and Sector From 2014-2022.” In the report, the EEOC highlighted demographic disparities for workers in 56 STEM (science, technology, engineering, and mathematics) occupations and their hiring industries….By: Steptoe & Johnson…
-

SEC Division of Corporation Finance Statement on Certain Protocol Staking Activities
On May 29, 2025, the staff (“Staff”) of the Division of Corporation Finance of the U.S. Securities and Exchange Commission continued its recent pattern of issuing Staff guidance addressing cryptocurrency. The May 29 Staff statement, titled “Statement on Certain Protocol Staking Activities”, provides the Staff’s views on the staking of crypto assets (“Covered Crypto Assets”)…
-

The Federal Circuit Upholds Drug Dosing Regimen as Valid and Nonobvious
In Janssen Pharmaceuticals, Inc. v. Mylan Laboratories., the United States Court of Appeals for the Federal Circuit affirmed a district court ruling that a pharmaceutical dosing claim limitation was nonobvious despite prior art describing dosing regimens for the same active ingredient….By: DLA Piper
-

What is a “Clear and Unmistakable” Prosecution History Disclaimer?
The Federal Circuit’s March 21, 2025 decision in Maquet Cardiovascular LLC v. Abiomed Inc. et al. (No. 2023-2045) and the recent Patent Trial and Appeal Board (PTAB) Delegated Rehearing Panel decision in SynAffix B.V. v. Hangzhou DAC Biotech Co., Ltd. (IPR 2022-01531, Paper 23) have provided new insights into how courts determine the applicability and…
-

DJI Says “Bring It On” to U.S. Drone Security Scrutiny
In a surprising move, China-based DJI, the world’s largest drone manufacturer, is not flinching at the prospect of tighter U.S. restrictions on Chinese drone companies. In fact, they’re embracing it….By: Robinson+Cole Data Privacy + Security Insider
-

Should You File a Slip and Fall Claim? Here’s What You Need to Know
If you were injured in a slip and fall accident, should you file a claim? Injuries from slip and fall accidents can be incredibly expensive, so it is important to make an informed decision about asserting your legal rights. Slip and fall accident victims will be entitled to just compensation in many cases, and an…